---
title: "VRXA.US (VRXA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VRXA.US/news.md"
symbol: "VRXA.US"
name: "VRXA.US"
parent: "https://longbridge.com/en/quote/VRXA.US.md"
datetime: "2026-06-13T19:28:39.601Z"
locales:
  - [en](https://longbridge.com/en/quote/VRXA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VRXA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VRXA.US/news.md)
---

# VRXA.US (VRXA.US) — Related News

### [VERAXA Biotech (NASDAQ: VRXA) Is ‘One to Watch’](https://longbridge.com/en/news/289628511.md)
*2026-06-12T18:05:43.000Z*
> VERAXA Biotech (NASDAQ: VRXA) Is ‘One to Watch’

### [](https://longbridge.com/en/news/289618285.md)
*2026-06-12T14:39:31.000Z*
> Veraxa Biotech shares are trading lower amid post-IPO volatility.

### [Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...](https://longbridge.com/en/news/289544374.md)
*2026-06-12T03:59:02.000Z*
> Top biotech gainers included Gelteq (up 197%) on clinical trial progress, Adial Pharmaceuticals (up 38%) after acquiring

### [U.S. Stock Market Midday Update: Voyager Acquisition up 16.67%, trading volume surges, market sentiment is high but beware of volatility risks](https://longbridge.com/en/news/287660918.md)
*2026-05-26T16:17:35.000Z*
> Voyager Acquisition rose 16.67%; Destiny Tech100 rose 2.66%, with a transaction volume of USD 381 million; BlackRock ros

### [U.S. stock market update: Voyager Acquisition down 23.01%, trading volume surges, market sentiment fluctuations attract attention](https://longbridge.com/en/news/286129803.md)
*2026-05-12T16:02:40.000Z*
> Voyager Acquisition fell 23.01%; Destiny Tech100 fell 29.43%, with a transaction volume of USD 456 million; KKR Group fe

### [U.S. stock market movement update: Quantum technology sector rebounds strongly, Xanadu up nearly 49%, Huachen AI up over 44%](https://longbridge.com/en/news/283715842.md)
*2026-04-22T20:00:13.000Z*
> The market overview of US stocks in the past hour shows a clear divergence between strong and weak performances, with te